ESR1 and cancer: Other baseline characteristics of the patients enrolled in the study including Nottingham grade of cancer; type of anthracycline; number of anthracycline cycles; second-line drugs; and blood relatives with cancer, marital state, diabetes, dyslipidemia, ER, PR, and Her 2 receptor status were presented as percentage frequencies in Table 2.